Sabra Healthcare REIT (NASDAQ:SBRA) Earns Outperform Rating from Analysts at Huntington

Stock analysts at Huntington initiated coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a note issued to investors on Thursday, Briefing.com reports. The brokerage set an “outperform” rating and a $23.00 price target on the real estate investment trust’s stock. Huntington’s price objective would indicate a potential upside of 10.63% from the stock’s current price.

Several other equities analysts have also issued reports on SBRA. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research note on Wednesday, July 22nd. Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Barclays upped their target price on shares of Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, August 31st. Seven investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.23.

Sabra Healthcare REIT Stock Down 0.1%

SBRA stock opened at $20.79 on Thursday. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.77. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The firm has a market cap of $5.31 billion, a PE ratio of 79.96, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. The business has a 50 day moving average of $20.68 and a 200 day moving average of $20.20.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The company had revenue of $230.11 million during the quarter, compared to the consensus estimate of $219.39 million. During the same period last year, the firm posted $0.38 earnings per share. The company’s revenue was up 24.7% compared to the same quarter last year. On average, research analysts forecast that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.

Insider Activity at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by company insiders.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently bought and sold shares of SBRA. Rothschild Investment LLC grew its stake in shares of Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares during the period. Smartleaf Asset Management LLC lifted its position in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the period. Versant Capital Management Inc boosted its holdings in Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the last quarter. Danske Bank A S purchased a new stake in Sabra Healthcare REIT in the third quarter worth approximately $30,000. Finally, Larson Financial Group LLC grew its position in Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares during the period. Institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.